AVLN Avalyn Pharma Inc. - common stock
$40,03
Harga · Agu 19, 2026
Fundamental per Agu 12, 2026
Rentang 52M
$24–$40
99% of range
Peringkat Analis
BUY
10 analysts
Target Harga
$60
+50% upside
P/E (TTM)
—
ROE
—
Margin Laba Bersih
—
AVLN Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$40.03
Kapitalisasi Pasar
—
P/E (TTM)
—
EPS (TTM)
—
Pendapatan (TTM)
—
Imbal Hasil Dividen
—
ROE
—
D/E Utang/Ekuitas
—
Rentang 52M
$24 – $40
AVLN Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
—
EPS
—
Arus Kas Bebas
—
Margin
—
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
AVLN
Median Rekan
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
AVLN
Median Rekan
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
AVLN
Median Rekan
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
AVLN
Median Rekan
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
AVLN
Median Rekan
AVLN Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
10 analis
- Beli Kuat 4 40,0%
- Beli 5 50,0%
- Tahan 1 10,0%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
4 analis · 2026-08-17
Median
$54.50
Rata-rata
$60.00
← Di bawah semua target
$40.03
Rendah
$51.00
Tinggi
$80.00
Target median
$54.50
+36,1%
Target rata-rata
$60.00
+49,9%
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| AVLN | — | — | — | — | — | — |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | — |
| KARD | — | — | — | — | — | — |
| TRLV | — | — | -0.45% | -10.3% | -10.4% | 60.2% |
| ANIP | $1.78B | 23.8 | 43.8% | 8.9% | 16.6% | — |
| ETON | $457M | — | 104.9% | -5.8% | -18.4% | 53.5% |
| LBRX | $563M | -7.1 | — | — | -25.5% | — |
| INVA | — | 6.1 | 14.7% | — | — | — |
| MAZE | $2.04B | -13.6 | — | — | -598.9% | — |
| HROW | $1.82B | -350.0 | 36.4% | -1.9% | -8.4% | 75.0% |
| XERS | $1.30B | — | 43.7% | 0.19% | -19.7% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Neraca 20
| Metrik | Tren | 2025 |
|---|---|---|
| Cash & Equivalents | $52M | |
| Short-term Investments | $86M | |
| Prepaid Expense | $5M | |
| Current Assets | $144M | |
| PP&E (Net) | $792.0K | |
| PP&E (Gross) | $846.0K | |
| Accum. Depreciation | $54.0K | |
| Other Non-current Assets | $3M | |
| Total Assets | $149M | |
| Accounts Payable | $4M | |
| Accrued Liabilities | $10M | |
| Current Liabilities | $14M | |
| Capital Leases | $1M | |
| Total Liabilities | $15M | |
| Common Stock | $24.0K | |
| Retained Earnings | $-265M | |
| AOCI | $134.0K | |
| Stockholders' Equity | $-239M | |
| Liabilities + Equity | $149M | |
| Shares Outstanding | 1,227,186 |
Laporan Laba Rugi 13
| Metrik | Tren | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| R&D Expense | $25M | $23M | $15M | |
| SG&A Expense | $7M | $5M | $3M | |
| Operating Expenses | $31M | $28M | $19M | |
| Operating Income | $-31M | $-28M | $-19M | |
| Interest Income | $3M | $1M | $1M | |
| Other Non-op | $-69.0K | $13.0K | $-35.0K | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-29M | $-27M | $-18M | |
| EPS (Basic) | $-0.98 | $-21.83 | $-63.24 | |
| EPS (Diluted) | $-0.98 | $-21.83 | $-63.24 | |
| Shares (Basic) | 29,650,660 | 1,230,698 | 276,792 | |
| Shares (Diluted) | 29,650,660 | 1,230,698 | 276,792 | |
| EBITDA | $-31M | $-28M | · |
Neraca 22
| Metrik | Tren | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $264M | $92M | · | |
| Short-term Investments | $88M | $31M | · | |
| Prepaid Expense | $6M | $7M | · | |
| Current Assets | $358M | $130M | · | |
| PP&E (Net) | $1M | $1M | · | |
| PP&E (Gross) | $1M | $1M | · | |
| Accum. Depreciation | $216.0K | $117.0K | · | |
| Other Non-current Assets | $3M | $3M | · | |
| Total Assets | $425M | $136M | · | |
| Accounts Payable | $3M | $3M | · | |
| Accrued Liabilities | $7M | $8M | · | |
| Current Liabilities | $11M | $12M | · | |
| Capital Leases | $1M | $1M | · | |
| Total Liabilities | $27M | $28M | · | |
| Long-term Debt | $15M | $15M | · | |
| Total Debt | $15M | $15M | · | |
| Common Stock | $67.0K | $24.0K | · | |
| Retained Earnings | $-321M | $-292M | · | |
| AOCI | $-95.0K | $12.0K | · | |
| Stockholders' Equity | $398M | $-264M | · | |
| Liabilities + Equity | $425M | $136M | · | |
| Shares Outstanding | 44,333,094 | 1,232,442 | · |
Arus Kas 8
| Metrik | Tren | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Stock-based Comp | $3M | $1M | $543.0K | |
| Operating Cash Flow | $-26M | $-30M | $-19M | |
| CapEx | $269.0K | $318.0K | $8.0K | |
| Investing Cash Flow | $-119M | $55M | $24M | |
| Stock Issued | · | $50M | · | |
| Net Stock Activity | · | $50M | · | |
| Financing Cash Flow | $317M | $15M | $0 | |
| Free Cash Flow | · | $-30M | · |
Profitabilitas 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| ROA | -13.6% | -39.6% | · | |
| ROE | -14.5% | 20.3% | · |
Likuiditas & Solvabilitas 4
| Metrik | Tren | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Current Ratio | 33.1 | 11.0 | · | |
| Quick Ratio | 32.6 | 10.4 | · | |
| Debt / Equity | 0.0 | -0.1 | · | |
| LT Debt / Equity | 0.0 | -0.1 | · |
Valuasi (TTM) 5
| Metrik | Tren | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Market Cap | $1.46B | · | · | |
| Enterprise Value | $1.12B | · | · | |
| P/B | 3.7 | · | · | |
| P / Tangible Book | 3.7 | · | · | |
| EV / EBITDA | -35.9 | · | · |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Orang dalam perusahaan 13 orang dalam · 5 pejabat · 6 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Lyn Baranowski | Chief Executive Officer | 29 April 2026 A | — | 0 | 0 | $0 |
| Douglas R Carlson | Chief Financial Officer | 30 April 2026 A | — | 0 | 0 | $0 |
| Melissa Rhodes | Chief Operating Officer | 29 April 2026 A | — | 0 | 0 | $0 |
| Adam H. Golden | General Counsel | 29 April 2026 A | — | 0 | 0 | $0 |
| Howard Lazarus | Chief Medical Officer | 29 April 2026 A | — | 0 | 0 | $0 |
| Jill Carroll | Direktur | 1 Mei 2026 C | 2.186.562 | 1 | 0 | $5.000.004 |
| Erin Lavelle | Direktur | 30 April 2026 A | — | 0 | 0 | $0 |
| Kate Haviland | Direktur | 29 April 2026 A | — | 0 | 0 | $0 |
| Jon Congleton | Direktur | 29 April 2026 A | — | 0 | 0 | $0 |
| Heather D Turner | Direktur | 29 April 2026 A | — | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | Pemilik 10% | 1 Mei 2026 C | 1.275.486 | 0 | 0 | $0 |
| FMR LLC | Pemilik 10% | 1 Mei 2026 C | 2.284.535 | 0 | 0 | $0 |
| Novo Holdings A/S | — | 1 Mei 2026 C | 3.883.289 | 1 | 0 | $9.999.990 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 2 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| SR One Capital Management, LLC, SR One Capital Fund II Aggregator, LP, SR One Capital Partners II, LP, AMZL, LP, SR One Capital SMA Partners, LP, Simeon George | 8 Mei 2026 | 7,50% | Pengajuan awal | Investasi pasif | SEC |
| SUVRETTA CAPITAL MANAGEMENT, LLC, Averill Master Fund, Ltd., Averill Madison Master Fund, Ltd., Aaron Cowen | 8 Mei 2026 | 5,60% | Pengajuan awal | Kampanye dewan | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 14 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,03% | 2.423 SH | 8 Agu 2026 | Harian |
| IWO · iShares Trust | 0,02% | 108.087 SH | 8 Agu 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 98.545 SH | 8 Agu 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 12.713 SH | 8 Agu 2026 | Harian |
| IWM · iShares Trust | 0,02% | 426.636 SH | 8 Agu 2026 | Harian |
| IWN · iShares Trust | 0,01% | 48.610 SH | 8 Agu 2026 | Harian |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 192.602 SH | 8 Agu 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 4.638 SH | 8 Agu 2026 | Harian |
| BNDX · VANGUARD CHARLOTTE FUNDS | 0,01% | 16.035.000 PA | 8 Agu 2026 | Harian |
| ISCB · iShares Trust | 0,01% | 852 SH | 8 Agu 2026 | Harian |
| IWV · iShares Trust | 0,00% | 6.674 SH | 8 Agu 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 534.440 SH | 8 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.442 SH | 8 Agu 2026 | Harian |
| BNDW · VANGUARD SCOTTSDALE FUNDS | 0,00% | 120.332 PA | 8 Agu 2026 | Harian |